RBC Capital Sticks to Their Sell Rating for British American Tobacco (BATS)
RBC Capital analyst James Edwardes Jones maintained a Sell rating on British American Tobacco today and set a price target of £36.00.
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Edwardes Jones covers the Consumer Defensive sector, focusing on stocks such as Diageo, Unilever, and Reckitt. According to TipRanks, Edwardes Jones has an average return of 4.3% and a 65.22% success rate on recommended stocks.
British American Tobacco has an analyst consensus of Moderate Buy, with a price target consensus of p5,027.27.
Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion
Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- BAT sticks to 2026 guidance as New Category growth and U.S. momentum underpin outlook
- British American Tobacco Issues Shares Under Employee Sharesave Scheme
- BAT Updates Market on Share Capital and Voting Rights
- BAT Reduces Share Count with Latest Buyback Tranche
- British American Tobacco Discloses Director Share Acquisition via Dividend Reinvestment
